Home007570 • KRX
add
Ilyang Pharmaceutical Co., Ltd
Previous close
â‚©13,230.00
Day range
â‚©12,960.00 - â‚©13,430.00
Year range
â‚©12,300.00 - â‚©16,250.00
Market cap
253.80B KRW
Avg Volume
25.50K
P/E ratio
416.54
Dividend yield
1.15%
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 82.70B | -3.11% |
Operating expense | 42.20B | -11.06% |
Net income | 1.09B | 137.27% |
Net profit margin | 1.31 | 138.42% |
Earnings per share | — | — |
EBITDA | 5.61B | -9.79% |
Effective tax rate | 21.45% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 24.62B | 66.57% |
Total assets | 496.67B | 7.71% |
Total liabilities | 228.31B | 16.61% |
Total equity | 268.36B | — |
Shares outstanding | 17.97M | — |
Price to book | 1.04 | — |
Return on assets | 1.38% | — |
Return on capital | 1.86% | — |
Cash Flow
Net change in cash
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 1.09B | 137.27% |
Cash from operations | 6.86B | 194.27% |
Cash from investing | -12.01B | -758.15% |
Cash from financing | 2.76B | 727.52% |
Net change in cash | -2.05B | -322.49% |
Free cash flow | -3.66B | -29.52% |
About
Founded
1946
Website
Employees
651